We are live on ! Find out more
PHGE icon

BiomX
PHGE

18 hedge funds and large institutions have $4.92M invested in BiomX in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.62% less ownership

Funds ownership: 2.82% → 2.2% (-0.62%)

10% less funds holding

Funds holding: 20 → 18 (-2)

34% less capital invested

Capital invested by funds: $7.44M → $4.92M (-$2.52M)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$974K
2
Renaissance Technologies
Renaissance Technologies
New York
+$13.3K
3
XT
XTX Topco
Cayman Islands
+$13.1K
4
SS
SBI Securities
Japan
+$50

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$993K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$884K
3
AI
Allostery Investments
Connecticut
-$523K
4
WAM
Warberg Asset Management
Illinois
-$10.3K
5
HCM
Heights Capital Management
California
-$8.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$1.12M – – –
NCM
2
Nantahala Capital Management
Connecticut
$1.12M – – –
Morgan Stanley
3
Morgan Stanley
New York
$834K +$974K +97,581 New
ACM
4
AIGH Capital Management
Maryland
$705K – – –
IC
5
Ikarian Capital
Texas
$402K – – –
JP Morgan Chase
6
JP Morgan Chase
New York
$194K – – –
DCM
7
DAFNA Capital Management
California
$181K – – –
ACM
8
ADAR1 Capital Management
Texas
$135K – – –
BFM
9
Boothbay Fund Management
New York
$107K – – –
JJ
10
Johnson & Johnson
New Jersey
$42.6K – – –
WAM
11
Warberg Asset Management
Illinois
$36K -$10.3K -1,032 -20%
Renaissance Technologies
12
Renaissance Technologies
New York
$11.4K +$13.3K +1,332 New
Barclays
13
Barclays
United Kingdom
$11.3K – – –
XT
14
XTX Topco
Cayman Islands
$11.2K +$13.1K +1,310 New
TSS
15
Two Sigma Securities
New York
$4.75K -$2.82K -283 -34%
CS
16
Clear Street
New York
$1.02K -$50 -5 -4%
SS
17
SBI Securities
Japan
$180 +$50 +5 +31%
CWA
18
Carolina Wealth Advisors
South Carolina
$72 – – –
O
19
OrbiMed
New York
– -$993K -94,093 Closed
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
– -$884K -83,723 Closed
AI
21
Allostery Investments
Connecticut
– -$523K -49,507 Closed
HCM
22
Heights Capital Management
California
– -$8.06K -763 Closed
UBS Group
23
UBS Group
Switzerland
– -$4.18K -395 Closed

PHGE Hedge Fund Activity: Q2 2025 in Review

18 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q2 2025, worth a combined $4.92M — down 34% from $7.44M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of PHGE and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $974K. The largest seller was OrbiMed, exiting entirely with an estimated $993K sold.

  • 18 institutional investors held BiomX (PHGE) as of Q2 2025, down from 20 in Q1 2025.
  • Funds reported $4.92M of BiomX stock for Q2 2025, down 34% quarter-over-quarter.
  • 3 funds opened new BiomX positions in Q2 2025 and 5 closed out, a net change of -2 holders.
  • The largest BiomX buyer in Q2 2025 was Morgan Stanley, an estimated $974K added.
  • The largest BiomX seller in Q2 2025 was OrbiMed, an estimated $993K sold.

Based on aggregated 13F filings for Q2 2025.